Nico Chen
Stock Analyst at DBS
(3.89)
# 1,881
Out of 5,073 analysts
124
Total ratings
59.2%
Success rate
9%
Average return
Main Sectors:
Stocks Rated by Nico Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1530 3SBio Inc. | Initiated Coverage: Buy | $17.80 | $14.33 | +24.21% | 1 | Oct 15, 2026 | |
| PFE Pfizer | Reiterated: Buy | $30 → $35 | $29.85 | +17.25% | 3 | Oct 8, 2026 | |
| HKG: 2675 Shenzhen Edge Medical Co., Ltd. | Reiterated: Buy | $51.40 | $31.68 | +62.25% | 2 | Sep 15, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $240 → $270 | $257.78 | +4.74% | 9 | Sep 11, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 → $180 | $149.88 | +20.10% | 5 | Sep 11, 2026 | |
| MRNA Moderna | Reiterated: Hold | $45 → $150 | $245.81 | -38.98% | 4 | Sep 11, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,333 → $1,550 | $1,270.75 | +21.98% | 10 | Aug 25, 2026 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Reiterated: Buy | n/a | $21.18 | - | 3 | Jul 23, 2026 | |
| ATR AptarGroup | Reiterated: Buy | $175 → $170 | $125.63 | +35.32% | 6 | Mar 18, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Hold | $480 | $428.12 | +12.12% | 1 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $93.03 | -3.26% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 | $297.60 | +51.21% | 1 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 140.00 → CHF 190.00 | CHF 130.20 | +45.93% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $183 → $230 | $284.80 | -19.24% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €59.00 → €52.00 | €41.71 | +24.67% | 3 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 657.80 → CHF 670.00 | CHF 623.60 | +7.44% | 4 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $100 | $69.01 | +44.91% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $320 | $393.48 | -18.67% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $400 | $438.34 | -8.75% | 6 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $700 → $910 | $805.67 | +12.95% | 2 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $540 | $524.52 | +2.95% | 1 | Jan 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23.40 → $36.00 | $49.40 | n/a | 9 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $40.97 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $125 | $153.57 | n/a | 2 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $194.34 | n/a | 5 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $459.40 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $44.51 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.08 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.97 | n/a | 1 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,200 | ¥2,453 | n/a | 2 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.40 | $3.26 | n/a | 3 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.85 | n/a | 4 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $90.80 | n/a | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29.30 | $15.90 | n/a | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $26.20 | n/a | 2 | Nov 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $30 | $18.82 | n/a | 2 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €120.00 | €32.08 | n/a | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $189 | $344.87 | n/a | 1 | Aug 22, 2023 |
3SBio Inc.
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $17.80
Current: $14.33
Upside: +24.21%
Pfizer
Oct 8, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $29.85
Upside: +17.25%
Shenzhen Edge Medical Co., Ltd.
Sep 15, 2026
Reiterated: Buy
Price Target: $51.40
Current: $31.68
Upside: +62.25%
Johnson & Johnson
Sep 11, 2026
Reiterated: Hold
Price Target: $240 → $270
Current: $257.78
Upside: +4.74%
Merck & Co.
Sep 11, 2026
Reiterated: Buy
Price Target: $130 → $180
Current: $149.88
Upside: +20.10%
Moderna
Sep 11, 2026
Reiterated: Hold
Price Target: $45 → $150
Current: $245.81
Upside: -38.98%
Eli Lilly and Company
Aug 25, 2026
Reiterated: Buy
Price Target: $1,333 → $1,550
Current: $1,270.75
Upside: +21.98%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Jul 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.18
Upside: -
AptarGroup
Mar 18, 2026
Reiterated: Buy
Price Target: $175 → $170
Current: $125.63
Upside: +35.32%
Intuitive Surgical
Mar 18, 2026
Reiterated: Hold
Price Target: $480
Current: $428.12
Upside: +12.12%
Mar 18, 2026
Reiterated: Hold
Price Target: $90
Current: $93.03
Upside: -3.26%
Mar 18, 2026
Reiterated: Buy
Price Target: $450
Current: $297.60
Upside: +51.21%
Mar 17, 2026
Reiterated: Buy
Price Target: CHF 140.00 → CHF 190.00
Current: CHF 130.20
Upside: +45.93%
Feb 25, 2026
Reiterated: Hold
Price Target: $183 → $230
Current: $284.80
Upside: -19.24%
Feb 24, 2026
Reiterated: Buy
Price Target: €59.00 → €52.00
Current: €41.71
Upside: +24.67%
Feb 2, 2026
Reiterated: Buy
Price Target: CHF 657.80 → CHF 670.00
Current: CHF 623.60
Upside: +7.44%
Jan 28, 2026
Reiterated: Buy
Price Target: $80 → $100
Current: $69.01
Upside: +44.91%
Jan 28, 2026
Reiterated: Buy
Price Target: $265 → $320
Current: $393.48
Upside: -18.67%
Jan 22, 2026
Reiterated: Buy
Price Target: $365 → $400
Current: $438.34
Upside: -8.75%
Jan 22, 2026
Reiterated: Buy
Price Target: $700 → $910
Current: $805.67
Upside: +12.95%
Jan 19, 2026
Reiterated: Buy
Price Target: $540
Current: $524.52
Upside: +2.95%
Aug 26, 2025
Reiterated: Hold
Price Target: $23.40 → $36.00
Current: $49.40
Upside: n/a
Jun 3, 2025
Reiterated: Buy
Price Target: $66
Current: $40.97
Upside: n/a
May 30, 2025
Reiterated: Buy
Price Target: $100 → $125
Current: $153.57
Upside: n/a
May 21, 2025
Rated: Hold
Price Target: n/a
Current: $194.34
Upside: n/a
May 21, 2025
Rated: Hold
Price Target: n/a
Current: $459.40
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $130
Current: $44.51
Upside: n/a
Mar 3, 2025
Rated: Hold
Price Target: n/a
Current: $6.08
Upside: n/a
Mar 3, 2025
Rated: Hold
Price Target: n/a
Current: $9.97
Upside: n/a
Oct 15, 2024
Reiterated: Buy
Price Target: ¥3,200
Current: ¥2,453
Upside: n/a
Sep 2, 2024
Reiterated: Buy
Price Target: $6.40
Current: $3.26
Upside: n/a
Aug 22, 2024
Reiterated: Buy
Price Target: n/a
Current: $15.85
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $90.80
Upside: n/a
Mar 26, 2024
Reiterated: Buy
Price Target: $29.30
Current: $15.90
Upside: n/a
Nov 24, 2023
Reiterated: Buy
Price Target: $55
Current: $26.20
Upside: n/a
Nov 3, 2023
Reiterated: Hold
Price Target: $36 → $30
Current: $18.82
Upside: n/a
Oct 10, 2023
Reiterated: Buy
Price Target: €120.00
Current: €32.08
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $189
Current: $344.87
Upside: n/a